Our flow cytometry assays demonstrated the significant expansion of granzyme-B-positive CD8+ T cells and γδTCR-specific T cells in AIM, supporting that these cells are the significant responder cells in the host cellular immune response against EBV infection. The gene discussed is CD8A; the disease is Epstein-Barr virus infection.